Back

Long-term intrinsic cycling in human life-course antibody responses to influenza A(H3N2)

Yang, B.; Garcia-Carreras, B.; Lessler, J.; Read, J. M.; Zhu, H.; Metcalf, C. J. E.; Hay, J. A.; Kwok, K. O.; Shen, R.; Jiang, C. Q.; Guan, Y.; Riley, S.; Cummings, D.

2022-06-27 epidemiology
10.1101/2022.06.27.22276898 medRxiv
Show abstract

Over a life-course, human adaptive immunity to antigenically mutable pathogens exhibits competitive and facilitative interactions. We hypothesize that such interactions may lead to cyclic dynamics in immune responses over a lifetime. Here, we demonstrated a long-term periodicity (about 24 years) in individual antibody responses, by analyzing hemagglutination inhibition titers against 21 historical influenza A(H3N2) strains spanning 47 years from a cohort in Guangzhou, China. The reported cycles were robust to analytic and sampling approaches. Simulations suggested that individual-level cross-reaction between antigenically similar strains likely explain the reported cycle. We showed that the reported cycles are predictable at both individual and birth-cohort level and that cohorts show a diversity of phases of these cycles. Phase of cycle was associated with the risk of response to circulating strains, after accounting for age and pre-existing titers of the circulating strains. Our findings reveal the existence of long-term periodicities in individual antibody responses to A(H3N2). We hypothesize that these cycles are driven by pre-existing antibody responses blunting responses to antigenically similar pathogens (by preventing infection and/or robust antibody responses upon infection), leading to reductions in antigen specific responses over time until individuals increasing risk leads to an infection with an antigenically distant enough virus to generate a robust immune response. These findings could help disentangle cohort-effects from individual-level exposure histories, improve our understanding of observed heterogeneous antibody responses to immunizations, and inform targeted vaccine strategy.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 1%
18.3%
2
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 4%
12.1%
3
PNAS Nexus
147 papers in training set
Top 0.1%
8.1%
4
PLOS Computational Biology
1633 papers in training set
Top 5%
6.7%
5
Nature Communications
4913 papers in training set
Top 34%
4.8%
6
Journal of The Royal Society Interface
189 papers in training set
Top 0.9%
4.2%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 39%
3.5%
8
Science Advances
1098 papers in training set
Top 8%
3.0%
9
Cell Reports
1338 papers in training set
Top 21%
2.0%
10
iScience
1063 papers in training set
Top 11%
2.0%
11
Frontiers in Immunology
586 papers in training set
Top 4%
1.8%
12
Science
429 papers in training set
Top 14%
1.7%
13
PLOS Pathogens
721 papers in training set
Top 6%
1.6%
14
The Journal of Immunology
146 papers in training set
Top 1.0%
1.5%
15
BMC Medicine
163 papers in training set
Top 4%
1.5%
16
Evolution, Medicine, and Public Health
14 papers in training set
Top 0.2%
1.2%
17
Physical Review Research
46 papers in training set
Top 0.5%
1.2%
18
Proceedings of the Royal Society B: Biological Sciences
341 papers in training set
Top 5%
0.9%
19
Communications Biology
886 papers in training set
Top 19%
0.9%
20
mSystems
361 papers in training set
Top 7%
0.9%
21
Viruses
318 papers in training set
Top 5%
0.8%
22
Advanced Science
249 papers in training set
Top 18%
0.8%
23
Cell Genomics
162 papers in training set
Top 6%
0.8%
24
mBio
750 papers in training set
Top 11%
0.8%
25
PLOS Biology
408 papers in training set
Top 20%
0.7%
26
Virus Evolution
140 papers in training set
Top 2%
0.7%
27
Epidemics
104 papers in training set
Top 2%
0.7%
28
PLOS ONE
4510 papers in training set
Top 70%
0.7%
29
BMC Public Health
147 papers in training set
Top 6%
0.7%
30
Royal Society Open Science
193 papers in training set
Top 6%
0.6%